Live Attenuated and Killed Vaccines

Live Attenuated Vaccines:

• Introduction: Live attenuated vaccines use weakened forms of pathogens to stimulate an immune response without causing disease. Our recombinant technology ensures these vaccines are both effective and safe.
• Technology: We utilize recombinant DNA technology to produce live attenuated vaccines that maintain the efficacy of traditional vaccines while reducing potential risks associated with live pathogens.
• Development Process: Our process includes:
• • Strain Development: Engineering pathogens to create attenuated strains.
  • Preclinical Testing: Rigorous testing to ensure safety and immunogenicity.
  • Clinical Trials: Comprehensive trials to assess efficacy and safety in humans.
  • Manufacturing: Scalable production methods to meet global demand.
• Case Studies/Examples: Highlight successful applications of live attenuated vaccines, such as those for viral infections where traditional vaccines are commonly used.

Killed Vaccines:

• Introduction: Killed vaccines use inactivated pathogens to elicit an immune response. Our recombinant approach ensures that these vaccines are both potent and safe, suitable for a range of infectious diseases.
• Technology: We apply recombinant technology to enhance the stability and immunogenicity of killed vaccines, ensuring they provide long-lasting protection.
• Development Process: Our process includes:
  • Pathogen Inactivation: Safe and effective methods to kill pathogens without compromising their ability to stimulate an immune response.
  • Formulation: Developing a stable vaccine formulation that maintains efficacy.
  • Quality Control: Extensive testing to ensure safety and effectiveness.
  • Manufacturing: High-quality production facilities to ensure consistency and reliability.
• Case Studies/Examples: Showcase successful killed vaccines developed for diseases where inactivation is preferred over live attenuated approaches.